Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Summary

This pilot clinical trial studies vaccine therapy and temozolomide in treating patients with newly diagnosed glioblastoma. Vaccines made from a person's white blood cells mixed with tumor proteins may help the body build an effective immune response to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving vaccine therapy and temozolomide may be an effective treatment for glioblastoma.

Timeline

Start

2013-11-11

Primary completion

2016-11-16

Completion

2016-11-16

Drugs

Indications